A phase III randomized study of neoadjuvant chemotherapy (NAC) alone or   in combination with nivolumab (NIVO) +/- linrodostat mesylate, followed   by adjuvant postsurgical NIVO +/- linrodostat, in cisplatin-eligible   muscle invasive bladder cancer (MIBC).

Dokumenttyp:: Meeting Abstract
Autor(en):: Sonpavde, Guru; Necchi, Andrea; Gupta, Shilpa; Steinberg, Gary D.; Gschwend, Juergen; Van der Heijden, Michiel Simon; Richiero, Audrey; Lambert, Alexandre; Raybold, Bradley; Gajavelli, Srikanth; Zardavas, Dimitrios; Galsky, Matt D.
Titel:: A phase III randomized study of neoadjuvant chemotherapy (NAC) alone or in combination with nivolumab (NIVO) +/- linrodostat mesylate, followed by adjuvant postsurgical NIVO +/- linrodostat, in cisplatin-eligible muscle invasive bladder cancer (MIBC).
Zeitschriftentitel:: J Clin Oncol
Jahr:: 2020
Band / Volume:: 38 Suppl S
Heft / Issue:: 15
Print-ISSN:: 0732-183X
TUM Einrichtung:: Urologische Klinik und Poliklinik
BibTeX

Vorkommen: